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Abstract
The SPOT
2 technology for highly parallel synthesis of peptides on ﬂat surfaces in array
type format has evolved into a versatile toolbox for a variety of applications in proteomics
such as mapping protein-protein interactions and proﬁling the substrate speciﬁcity of
enzymes such as kinases and proteases. Originally developed for the synthesis of short
overlapping peptide sequences for mapping antibody epitopes this technology has recently
been extended to the synthesis of functional protein domains. This opens up a variety of
future applications such as target identiﬁcation and protein expression proﬁling. Copyright
# 2001 John Wiley & Sons, Ltd.
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Introduction
In contrast to the development of DNA array
technologies, the preparation and application of
peptide, protein domain and protein arrays is in its
very infancy. In the last few years it has become
obvious that the information obtained from DNA
chips is not sufﬁcient and has to be complemented
by information from the proteome. It is beyond any
doubt that protein chip technologies will play a
crucial role in deciphering the human proteome and
identifying new target proteins for therapeutic use.
Peptide/protein chips will furthermore play an
essential role in the future for individualised
diagnosis of the human health status, which is a
prerequisite for the development and application of
personalised medicines. The synthesis of peptide
and protein domain arrays by the SPOT technology
[4,7] is reported here, addressing the preparation
and the application of these arrays in various
aspects of proteomics research.
The SPOT technology involves the spatially
addressed synthesis of peptide arrays on ﬂat
surfaces. It was originally developed to synthesise
peptide scans on cellulose membranes for the
purpose of antibody epitope mapping [4,8]. Since
then, the SPOT technology has synthetically
evolved into automated peptide and protein
domain synthesis on various types of ﬂat surfaces
(cellulose, polypropylene, glass) using a variety of
chemistries for attaching the compounds to the
surface. This enables successive, highly parallel solid
or solution phase screenings of thousands of
different peptides and protein domains for biologi-
cal activity, such as binding or enzymatic activity
(for reviews see: [5,7,12]).
Preparation of arrays
The SPOT technology started with synthesis on
cellulose membranes, but other types of ﬂat surfaces
such as polypropylene [12] or glass (Schutkowski,
unpublished; [11]) have been used recently. The
compounds can be coupled by different chemistries
through several types of linkers to the ﬂat surfaces,
depending on the successive application of the
arrays. Very stable attachments via an ether bond,
for instance, ensure the reusability of the cellulose
membranes up to ten times for protein binding
studies. Attachment via an ester bond or a photo-
cleavable linker allows the selective cleavage of the
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Copyright # 2001 John Wiley & Sons, Ltd.compounds from the surface for the purpose of
quality control, or application of the compounds in
standard micro-titer plate assay systems [12]. Cur-
rently, densities up to 17 peptides/cm
2 can be
prepared on a 20r30 cm cellulose membrane by
stepwise SPOT synthesis in a semi- or fully
automated fashion (Zerweck, unpublished). By
applying printing technologies for the coupling of
peptides or protein domains synthesised by con-
ventional methods, much higher densities (>1000)
can be achieved, especially on non-porous glass
materials [6]; (Reimer and Schutkowski, un-
published).
Types of molecules
A variety of peptide molecules can be prepared by
the SPOT technique (Figure 1). Linear peptides can
routinely be synthesised up to a length of 20 amino
acids, the quality of which is similar compared to
standard methods [12]. In addition, much longer
peptides have been prepared by stepwise synthesis,
as shown for the synthesis of a WW protein domain
consisting of 42 amino acids [9]. The synthesis is
not restricted to linear L-peptides. D-enantiomers,
cyclic variants and phoshorylated or other modiﬁed
peptides can be readily prepared. An upcoming
application will be the combination of SPOT
synthesis and chemo-selective ligation techniques
(for review see: [2]) for the preparation of protein
domains by linking two or more peptides onto each
spot. This has been demonstrated for the synthesis
of several thousand variants of a WW protein
domain [10]. Within the near future this should lead
to molecules with lengths of up to 100 amino acids.
Applications of arrays
Numerous applications of synthetic peptide and
protein domain arrays have been reported or can be
preconceived (for reviews see: [7,5,11]): 1 Mapping
of protein-protein contact sites (antibody-antigen,
receptor-ligand, speciﬁcities of signaling protein
modules, etc.), 2 proﬁling of enzymatic activities
(kinases, proteases, transferases, etc.), 3 protein
expression proﬁling or 4 deciphering signal trans-
duction pathways. For the future applications,
3 and 4, the chips have to be incubated with cell
lysates [1] or even whole cells [3]. Combining the
SPOT technology with modern techniques in mass
spectrometry will allow a highly parallel identiﬁca-
tion of known or unknown proteins that bind to
distinct un/modiﬁed peptides or protein domains.
Another major application of peptide and protein
Figure . Different types of peptides can be synthesised either by stepwise manner or printed as arrays: (1) short linear
peptides (<20 mers), (2) peptides cyclised by different chemical strategies, (3) modiﬁed peptides (phosphorylated,
glycosylated etc.) and (4) protein domains (WW, SH2, SH3, PDZ etc.)
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diseases leading to detailed pictures of the health
status of single individuals.
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